Home/Filings/4/0000819050-22-000047
4//SEC Filing

Chadha Deepak 4

Accession 0000819050-22-000047

CIK 0000819050other

Filed

May 8, 8:00 PM ET

Accepted

May 9, 4:17 PM ET

Size

5.5 KB

Accession

0000819050-22-000047

Insider Transaction Report

Form 4
Period: 2022-05-05
Chadha Deepak
Chief Research & Dev. Officer
Transactions
  • Award

    Stock Option (right to buy)

    2022-05-05+325,000325,000 total
    Exercise: $0.26From: 2023-05-05Exp: 2032-05-05Common Stock (325,000 underlying)
Footnotes (1)
  • [F1]The stock options will vest 25% on the first anniversary of the grant date, and the remainder will vest in equal monthly installments over the following three years.

Issuer

Brickell Biotech, Inc.

CIK 0000819050

Entity typeother

Related Parties

1
  • filerCIK 0001784380

Filing Metadata

Form type
4
Filed
May 8, 8:00 PM ET
Accepted
May 9, 4:17 PM ET
Size
5.5 KB